Cargando…

Is it worth allowing the presence of morning stiffness in the definition of inactive disease in juvenile idiopathic arthritis?

Detalles Bibliográficos
Autores principales:	Allegra, Maddalena, Gallo, Maria Chiara, Verazza, Sara, Calandra, Serena, Dalprà, Sara, Mongelli, Federica, Martini, Alberto, Ravelli, Angelo, Consolaro, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4191158/ http://dx.doi.org/10.1186/1546-0096-12-S1-P174

Ejemplares similares

A prediction rule for lack of achievement of inactive disease with methotrexate as the sole disease-modifying antirheumatic therapy in juvenile idiopathic arthritis
por: Bava, Cecilia, et al.
Publicado: (2019)

PReS-FINAL-2132: Defining criteria for high disease activity in juvenile idiopathic arthritis: definition and validation of juvenile arthritis disease activity score cutoffs
por: Consolaro, A, et al.
Publicado: (2013)

Time of onset of iridocyclitis (IC) in children with juvenile idiopathic arthritis (JIA)
por: Verazza, S, et al.
Publicado: (2008)

Comparison of physician's, parent's and patient's global ratings made on linear or 21-circle visual analogue scales (VAS) in juvenile idiopathic arthritis (JIA)
por: Dalprà, S, et al.
Publicado: (2008)

Do parent's global rating of well-being and disease activity of children with juvenile idiopathic arthritis yield different information?
por: Ullmann, N, et al.
Publicado: (2008)

Agreement between objective and subjective definitions of inactive disease, remission and minimal disease activity in juvenile idiopathic arthritis
por: Schiappapietra, B, et al.
Publicado: (2011)

PReS-FINAL-2143: Treat-to-target strategy in juvenile idiopathic arthritis: experience in 175 newly-diagnosed patients
por: Negro, G, et al.
Publicado: (2013)

PReS-FINAL-2028: ANA positivity and a younger age at onset, but not disease category, predict the risk of uveitis in italian children with juvenile idiopathic arthritis
por: Schiappapietra, B, et al.
Publicado: (2013)

PReS-FINAL-2012: Introducing a new approach to clinical care of juvenile dermatomyositis: the juvenile dermatomyositis multidimensional assessment report
por: Varnier, GC, et al.
Publicado: (2013)

PReS-FINAL-2176: Declines in levels of disease activity and physical disability in children with juvenile idiopathic arthritis seen in standard clinical care over the last 25 years
por: Consolaro, A, et al.
Publicado: (2013)

Children with juvenile idiopathic arthritis currently followed in a tertiary care setting have a better psychosocial well-being than healthy peers
por: Bertamino, M, et al.
Publicado: (2011)

PReS-FINAL-2098: Evaluation of the disease course of Italian children with juvenile idiopathic arthritis treated with etanercept: preliminary results in 313 patients
por: Verazza, S, et al.
Publicado: (2013)

Clinical outcome measures in juvenile idiopathic arthritis
por: Consolaro, Alessandro, et al.
Publicado: (2016)

A new approach to defining inactive disease, minimal disease activity and parent- and child-acceptable symptom state in juvenile idiopathic arthritis
por: Consolaro, A, et al.
Publicado: (2011)

PReS-FINAL-2011: Preliminary validation of a new hybrid measure of muscle strength for juvenile dermatomyositis
por: Marafon, D, et al.
Publicado: (2013)

Comparison of the accuracy of different definitions of clinical remission (CR) and minimal disease activity (MDA) in juvenile idiopathic arthritis (JIA)
por: Davì, S, et al.
Publicado: (2008)

Is it worth including subtalar joint in ultrasound ankle assessment of patients with juvenile idiopathic arthritis?
por: Lanni, Stefano, et al.
Publicado: (2014)

A controlled trial of intra-articular corticosteroids with or without methotrexate in oligoarticular juvenile idiopathic arthritis
por: Bracciolini, GP, et al.
Publicado: (2014)

Drivers of non-zero physician global scores during periods of inactive disease in juvenile idiopathic arthritis
por: Alongi, Alessandra, et al.
Publicado: (2022)

Worth living or worth dying? The views of the general public about allowing disabled children to die
por: Brick, Claudia, et al.
Publicado: (2020)

The PRINTO provisional definition of remission in juvenile dermatomyositis
por: Lazarevic, D, et al.
Publicado: (2011)

Evaluation of the disease course of Italian children with juvenile idiopathic arthritis treated with etanercept: preliminary results in 772 patients
por: Verazza, Sara, et al.
Publicado: (2014)

Juvenile Idiopathic Arthritis: Diagnosis and Treatment
por: Giancane, Gabriella, et al.
Publicado: (2016)

Physical inactivity and arterial stiffness in COPD
por: Sievi, Noriane A, et al.
Publicado: (2015)

Long‐Term Outcomes Following Achievement of Clinically Inactive Disease in Juvenile Idiopathic Arthritis: The Importance of Definition
por: Shoop‐Worrall, Stephanie J. W., et al.
Publicado: (2018)

Defining clinical remission and clinically inactive disease in juvenile systemic lupus erythematosus (jSLE)
por: Mina, Rina, et al.
Publicado: (2011)

IL-1 Inhibition in Systemic Juvenile Idiopathic Arthritis
por: Giancane, Gabriella, et al.
Publicado: (2016)

Development and initial validation of a new functional ability tool for juvenile dermatomyositis
por: Varnier, GC, et al.
Publicado: (2011)

How common is clinically inactive disease in a prospective cohort of patients with juvenile idiopathic arthritis? The importance of definition
por: Shoop-Worrall, Stephanie J W, et al.
Publicado: (2017)

Final validation of a new composite disease activity score for juvenile idiopathic arthritis: the Juvenile Arthritis Disease Activity Score (JADAS)
por: Consolaro, A, et al.
Publicado: (2008)

Erratum: How common is clinically inactive disease in a prospective cohort of patients with juvenile idiopathic arthritis? The importance of definition
Publicado: (2017)

Impact of morning stiffness on working behaviour and performance in people with rheumatoid arthritis
por: Mattila, Kalle, et al.
Publicado: (2014)

Definition and Validation of the American College of Rheumatology 2021 Juvenile Arthritis Disease Activity Score Cutoffs for Disease Activity States in Juvenile Idiopathic Arthritis
por: Trincianti, Chiara, et al.
Publicado: (2021)

Juvenile Psoriatic Arthritis: Myth or Reality? An Unending Debate
por: Naddei, Roberta, et al.
Publicado: (2023)

Preliminary validation of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) in 403 clinic patients
por: Solari, N, et al.
Publicado: (2008)

Advanced bone age in the affected side predicts worse radiographic progression in patients with juvenile idiopathic arthritis and unilateral wrist disease
por: Varnier, Giulia Camilla, et al.
Publicado: (2014)

Analysis of ceiling effect and score distribution of outcome measures in juvenile idiopathic arthritis (JIA)
por: Lattanzi, B, et al.
Publicado: (2008)

PReS-FINAL-2193: Assessment of construct validity of new measures of global disease activity, physical function and quality of life in children with juvenile dermatomyositis
por: Ferrari, C, et al.
Publicado: (2013)

Severity and Diurnal Improvement of Morning Stiffness Independently Associate with Tenosynovitis in Patients with Rheumatoid Arthritis
por: Kobayashi, Yoshihisa, et al.
Publicado: (2016)

Is the absence of prolonged morning stiffness at the time of diagnosis of polymyalgia rheumatica a paraneoplastic warning?
por: Manzo, Ciro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0vkh4s4v3prkfa299b6sj0qgt6